Dehaier Medical to Become the Exclusive After-Sales Service Agent of HEYER Medical AG
April 24 2013 - 8:30AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that Dehaier becomes the
exclusive after-sales service agent of Heyer Medical AG ("Heyer")
for its anesthesia machine and ultrasound nebulizer products.
Under the agreement, Dehaier will be the exclusive technical
service provider in mainland China for all Heyer products sold in
the country, including product installation, user training,
maintenance and product upgrading. The agreement also extends
Dehaier's exclusive distribution authorization for Heyer anesthesia
machines and ultrasound nebulizers for two years. Mr. Ping Chen,
Chairman and CEO of Dehaier, noted, "We are pleased to deepen our
cooperation with Heyer and look forward to sharing Heyer's
high-quality medical products in China."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
About Heyer Medical
Founded in 1883, Heyer became an innovator in inhalation
technology for the treatment of respiratory tract diseases. Today
HEYER is an internationally acknowledged specialist in
state-of-the-art inhalation and anesthesia equipment, oxygen
concentrators, breathing therapy equipment and connecting
equipment. The products are used all over the world, particularly
in the medical field, in clinics and practices in Europe and Asia
as well as in the Middle East, South America and the USA. Their
inhalation equipment is also increasingly used in wellness
applications and for treatment and care at home.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding the implementation of the
Heyer agreement. These statements are subject to uncertainties and
risks including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024